TY  - GEN
AU  - Montes, Ariana
AU  - Perez-Pampin, Eva
AU  - Navarro-Sarabia, Federico
AU  - Moreira, Virginia
AU  - Rodríguezde la Serna, Arturo
AU  - Magallares, Berta
AU  - Vasilopoulos, Yiannis
AU  - Sarafidou, Theologia
AU  - Fernández-Nebro, Antonio
AU  - Ordóñez, María Del Carmen
AU  - Narváez, Javier
AU  - Cañete, Juan D
AU  - Marquez, Ana
AU  - Pascual-Salcedo, Dora
AU  - Joven, Beatriz
AU  - Carreira, Patricia
AU  - Moreno-Ramos, Manuel J
AU  - Caliz, Rafael
AU  - Ferrer, Miguel Angel
AU  - Garcia-Portales, Rosa
AU  - Blanco, Francisco J
AU  - Magro, Cesar
AU  - Raya, Enrique
AU  - Valor, Lara
AU  - Alegre-Sancho, Juan J
AU  - Balsa, Alejandro
AU  - Martin, Javier
AU  - Plant, Darren
AU  - Isaacs, John
AU  - Morgan, Ann W
AU  - Barton, Anne
AU  - Wilson, Anthony G
AU  - Gómez-Reino, Juan J
AU  - Gonzalez, Antonio
PY  - 2015
DO  - 10.1186/s13075-015-0571-z
SN  - 1478-6354
UR  - http://hdl.handle.net/20.500.12105/17083
AB  - INTRODUCTION: We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of these anti-tumor necrosis factor...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Artritis reumatoide
KW  - Genotipo
KW  - Articulaciones
KW  - Enfermedades reumáticas
KW  - Factor de necrosis tumoral alfa
KW  - Arthritis, Rheumatoid
KW  - Genotype
KW  - Humans
KW  - Joints
KW  - Rheumatic Diseases
KW  - Tumor Necrosis Factor-alpha
KW  - Tumor Necrosis Factors
TI  - Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.
TY  - research article
ER  -